tiprankstipranks
Trending News
More News >
Merus announces common shares offering, no amount given
PremiumThe FlyMerus announces common shares offering, no amount given
3d ago
Merus’s Strong Clinical Data and Financial Stability Justify Buy Rating
Premium
Ratings
Merus’s Strong Clinical Data and Financial Stability Justify Buy Rating
5d ago
Merus Announces Promising Phase 2 Trial Results
Premium
Company Announcements
Merus Announces Promising Phase 2 Trial Results
9d ago
Merus price target raised to $110 from $96 at BMO Capital
PremiumThe FlyMerus price target raised to $110 from $96 at BMO Capital
15d ago
Merus price target raised to $92 from $70 at BofA
Premium
The Fly
Merus price target raised to $92 from $70 at BofA
15d ago
Promising Potential of Merus’s Petosemtamab: A Buy Rating Backed by Impressive Efficacy and Safety
Premium
Ratings
Promising Potential of Merus’s Petosemtamab: A Buy Rating Backed by Impressive Efficacy and Safety
15d ago
Merus Shareholders Approve Key Proposals at AGM
PremiumCompany AnnouncementsMerus Shareholders Approve Key Proposals at AGM
16d ago
Merus’s HNSCC Program Potential Drives Buy Rating Amid Market Opportunities and Challenges
Premium
Ratings
Merus’s HNSCC Program Potential Drives Buy Rating Amid Market Opportunities and Challenges
17d ago
Promising Developments in Cancer Treatment Drive Buy Rating for Merus with $67 Price Target
Premium
Ratings
Promising Developments in Cancer Treatment Drive Buy Rating for Merus with $67 Price Target
17d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100